Sandbox Reserved 1660

From Proteopedia

(Difference between revisions)

Revision as of 19:57, 11 January 2022

This Sandbox is Reserved from 26/11/2020, through 26/11/2021 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1643 through Sandbox Reserved 1664.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
Click the 3D button (when editing, above the wikitext box) to insert Jmol.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Structure of mouse CD1d expressed in SF9 cells, no ligand added (PDB entry : 3GMQ)

Drag the structure with the mouse to rotate

Structure of mouse CD1d

CD1 (Cluster of Differentiation 1) is a family of glycoproteins involved in the presentation of antigens on the surface of specific cells to NKT cells. Among these CD1-presenting cells can be counted splenic dendritic cells, marginal zone B cells and CD4+CD8+ thymocytes. This family is made of two main groups: group 1 is composed of CD1a, b and c proteins and group 2 is composed of CD1d proteins. The third group is the CD1e, which shares some partial characteristics from groups 1 and 2^[1] ^[2].
Thus, the structure and function of such proteins in mice are akin to those of humans. Mice doesn’t express group 1 CD1 molecules. Instead, they have two kinds of CD1d molecules. Therefore, they have been widely used to characterize the functions of CD1d and CD1d-dependent NKT cells in many diseases.

1 Structure of mouse CD1d
2 Function
- 2.1 Role in the immune system
- 2.2 Ligands presented by CD1d
3 Structure
4 Impact of ligand-binding
- 4.1 Conformational variation
- 4.2 CD1d affinity
5 Applications
- 5.1 Immunotherapeutic tool
- 5.2 NKT cells marker
6 See Also
7 References

Function

CD1d dependent lipid antigen presentation.

Role in the immune system

CD1d protein is a molecule of the immune system, involved in presenting a lipid antigen to NKT cells. Indeed, these proteins are located on the surface of the plasma membrane of APC cells. When the recognition between the CD1d bound to its lipid ligand and the TCR of a NKT cell occurs, the lymphocyte turns out to be activated. Thus, the production of cytotoxic molecules such as interleukin-4 and IFN-gamma is triggered by this activation, leading to either a Th2 or Th1 immune response respectively ^[3]^[4]. Therefore, CD1d proteins are precursors of the adaptive immune reaction. As a result, a deficiency of CD1d protein may lead to a deficiency of the NKT cells functioning and thus to autoimmune diseases and cancers.

Ligands presented by CD1d

The ligands that can be presented by CD1d to NKT or other CD1d-restricted T cells are very specific, because the recognition is based on an hydrophobic interaction between the ligand and the CD1d molecule. Thus, it limits the risk of other similar molecules or binding CD1d proteins and ensures that the immune response is accurate. Among these molecules are included glycolipids from a marine sponge : alphagalactosylceramide (alphaGalCer), bacterial glycolipids, normal endogenous glycolipids, tumor-derived phospholipids and glycolipids, and nonlipidic molecules^[5].

Structure

is made of 2 chains ^[6]:

- an (T-cell surface glycoprotein CD1d1) of 287 amino acids

- a of 99 amino acids.

The first chain is made of two beta-sheets and a set of 2 alpha helix. Each beta-sheet contains four antiparallel strands. The ligand binds between the two alpha-helices. Additionally, there are five ^[6] bound to the alpha chain via N-glycosylations, three of which have been clearly identified^[7]. The total molecular weight of the alpha chain is 33 kDa when not associated to any oligosaccharide and 55 kDa when the five oligosaccharides are bound to the chain.
CD1d molecules are structurally similar to Major Histocompatibility Complex Class I, but present lipid antigens as opposed to peptides and the cleft where the ligand can bind its protein is different between MHC molecules and CD1d molecules. Indeed, the hydrophobic cleft of CD1d has a narrow opening.The recognition between the protein and its ligand occurs at a specific spot which creates an appropriate environment for the interaction to happen. This is located at the A and F pockets in the region of the alpha helices^[8].

Impact of ligand-binding

Conformational variation

NTK cells are a subset of T cells (which play a central role in the immune response) that are activated by CD1d-glycolipid complexes. α-GalCer is a potent NKT cell agonist when presented by CD1d. The stability of the CD1d-glycolipid complexes has an impact on the cytokine release (cell signaling). Conformational variations that would stabilize the F’-pocket (primary site of interaction with the T cell receptor, NKT TCR) might increase CD1d affinity for the NKT TCR^[4]^[8].

between CD1d no ligand and structure of bovine CD1d with bound C12-di-sulfatide.

CD1d affinity

CD1d proteins lipid recognition is based on the interaction of the protein with its ligand. Nevertheless, the interaction relies on two recognitions. The first one is the recognition of the head of the lipid and the second one is the recognition of the length of the molecule. Because there are more than one condition to fill in order to interact with CD1d proteins, the affinity for a lipid depends itself on a plurality of parameters which modulates it^[4]^[8]^[9].

Applications

Immunotherapeutic tool

The presentation of many of ligands can have immunopotentiating effects, such as serving as an adjuvant in malaria vaccine or resulting in a more rapid clearance of certain virus infections. They can also be protective in autoimmune diseases or cancer^[4]^[5]^[10].

The orientation of the immune pathway (Th1 or Th2) due to the cytokines secretion by NKT cells is dependant of the affinity of the ligand for CD1 molecule. The design of agonists with a higher or lower affinity for CD1 could also leads to therapeutic effects, due to the possibility of specifically directing the immune response towards the Th1 or Th2 pathway ^[8] ^[11].

NKT cells marker

CD1 molecules can also be used as NKT cell markers. Indeed, a CD1 molecule can be engineered to become fluorescent by binding a fluorescent-potent molecule to it. When the engineered complex interacts with a NKT cell, the fluorescent signal is emitted and therefore the NKT cells can be spotted^[12].

References

↑ Jullien, D.; Afanassieff, M.; Claudy, A.; Nicolas, J.; Kaiserlian, D. CD1 : une nouvelle famille de molécules présentatrices d’antigènes aux caractéristiques singulières. Med Sci (Paris) 1999, 15 (1), 7. https://doi.org/10.4267/10608/1190.
↑ Angenieux C, Salamero J, Fricker D, Cazenave JP, Goud B, Hanau D, de La Salle H. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem. 2000 Dec 1;275(48):37757-64. doi: 10.1074/jbc.M007082200. PMID: 10948205.
↑ Joyce, S. CD1d and Natural T Cells: How Their Properties Jump-Start the Immune System. CMLS, Cell. Mol. Life Sci. 2001, 58 (3), 442–469. https://doi.org/10.1007/PL00000869.
↑ ^4.0 ^4.1 ^4.2 ^4.3 Rossjohn, J., Pellicci, D. G., Patel, O., Gapin, L., & Godfrey, D. I. (2012). Recognition of CD1d-restricted antigens by natural killer T cells. Nature reviews. Immunology, 12(12), 845–857. https://doi.org/10.1038/nri3328.
↑ ^5.0 ^5.1 Brutkiewicz, R. R. CD1d Ligands: The Good, the Bad, and the Ugly. The Journal of Immunology 2006, 177 (2), 769–775. https://doi.org/10.4049/jimmunol.177.2.769.
↑ ^6.0 ^6.1 Information, N. C. for B.; Pike, U. S. N. L. of M. R.; BethesdaMD; 20894USA. 3GMQ: Structure of mouse CD1d expressed in SF9 cells, no ligand added https://www.ncbi.nlm.nih.gov/Structure/pdb/3GMQ (accessed Dec 5, 2020).
↑ Sriram, V., Willard, C.A., Liu, J., & Brutkiewicz, R.R.(2008). Importance of N-linked glycosylation in the functional expression of murine CD1d1. Immunology, 123:272–281.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2433293/
↑ ^8.0 ^8.1 ^8.2 ^8.3 Schiefner, A.; Fujio, M.; Wu, D.; Wong, C.-H.; Wilson, I. A. Structural Evaluation of Potent NKT-Cell Agonists: Implications for Design of Novel Stimulatory Ligands. J Mol Biol 2009, 394 (1), 71–82. https://doi.org/10.1016/j.jmb.2009.08.061
↑ McCarthy, C.; Shepherd, D.; Fleire, S.; Stronge, V. S.; Koch, M.; Illarionov, P. A.; Bossi, G.; Salio, M.; Denkberg, G.; Reddington, F.; Tarlton, A.; Reddy, B. G.; Schmidt, R. R.; Reiter, Y.; Griffiths, G. M.; van der Merwe, P. A.; Besra, G. S.; Jones, E. Y.; Batista, F. D.; Cerundolo, V. The Length of Lipids Bound to Human CD1d Molecules Modulates the Affinity of NKT Cell TCR and the Threshold of NKT Cell Activation. J Exp Med 2007, 204 (5), 1131–1144. https://doi.org/10.1084/jem.20062342.
↑ Sköld, M.; Behar, S. M. Role of CD1d-Restricted NKT Cells in Microbial Immunity. Infect Immun 2003, 71 (10), 5447–5455. https://doi.org/10.1128/IAI.71.10.5447-5455.2003.
↑ Kishi J, Inuki S, Hirata N, Kashiwabara E, Yoshidome D, Ichihara O, Fujimoto Y. Structure-activity relationship studies of Bz amide-containing α-GalCer derivatives as natural killer T cell modulators. Bioorg Med Chem Lett. 2019 Apr 15;29(8):970-973. doi: 10.1016/j.bmcl.2019.02.018. Epub 2019 Feb 18. PMID: 30824201.
↑ Benlagha, K., Weiss, A., Beavis, A., Teyton, L., & Bendelac, A. (2000). In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. The Journal of experimental medicine, 191(11), 1895–1903. https://doi.org/10.1084/jem.191.11.1895

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_1660"

@@ Line 5: / Line 5: @@
 <p align="justify">
-'''[[CD1]] (Cluster of Differentiation 1)''' is a family of glycoproteins involved in the presentation of antigens on the surface of specific cells to [https://en.wikipedia.org/wiki/Natural_killer_T_cell NKT cells]. Amongst these CD1-presenting cells can be counted splenic dendritic cells, marginal zone B cells and CD4+CD8+ thymocytes. This family is made of two main groups: group 1 is composed of CD1a, b and c proteins and group 2 is composed of CD1d proteins. The third group is the CD1e, which shares some partial characteristics from groups 1 and 2<ref>Jullien, D.; Afanassieff, M.; Claudy, A.; Nicolas, J.; Kaiserlian, D. CD1 : une nouvelle famille de molécules présentatrices d’antigènes aux caractéristiques singulières. Med Sci (Paris) 1999, 15 (1), 7. https://doi.org/10.4267/10608/1190.</ref> <ref>Angenieux C, Salamero J, Fricker D, Cazenave JP, Goud B, Hanau D, de La Salle H. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem. 2000 Dec 1;275(48):37757-64. doi: 10.1074/jbc.M007082200. PMID: 10948205.</ref>.
+'''[[CD1]] (Cluster of Differentiation 1)''' is a family of glycoproteins involved in the presentation of antigens on the surface of specific cells to [https://en.wikipedia.org/wiki/Natural_killer_T_cell NKT cells]. Among these CD1-presenting cells can be counted splenic dendritic cells, marginal zone B cells and CD4+CD8+ thymocytes. This family is made of two main groups: group 1 is composed of CD1a, b and c proteins and group 2 is composed of CD1d proteins. The third group is the CD1e, which shares some partial characteristics from groups 1 and 2<ref>Jullien, D.; Afanassieff, M.; Claudy, A.; Nicolas, J.; Kaiserlian, D. CD1 : une nouvelle famille de molécules présentatrices d’antigènes aux caractéristiques singulières. Med Sci (Paris) 1999, 15 (1), 7. https://doi.org/10.4267/10608/1190.</ref> <ref>Angenieux C, Salamero J, Fricker D, Cazenave JP, Goud B, Hanau D, de La Salle H. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem. 2000 Dec 1;275(48):37757-64. doi: 10.1074/jbc.M007082200. PMID: 10948205.</ref>.
 <br>
 Thus, the structure and function of such proteins in mice are akin to those of humans. Mice doesn’t express group 1 CD1 molecules. Instead, they have two kinds of CD1d molecules. Therefore, they have been widely used to characterize the functions of CD1d and CD1d-dependent NKT cells in many diseases.
@@ Line 36: / Line 36: @@
 <scene name='86/868193/Cd1d/4'>CD1d protein</scene> is made of 2 chains <ref name="Structure">Information, N. C. for B.; Pike, U. S. N. L. of M. R.; BethesdaMD; 20894USA. 3GMQ: Structure of mouse CD1d expressed in SF9 cells, no ligand added https://www.ncbi.nlm.nih.gov/Structure/pdb/3GMQ (accessed Dec 5, 2020).</ref>: <br>
 :- an <scene name='86/868193/Alpha_chain/6'>alpha chain</scene> (T-cell surface glycoprotein CD1d1) of 287 amino acids <br>
-:- a <scene name='86/868193/Beta-2-microglobulin_chain/6'>beta-2-microglobulin chain</scene> of 99 amino acids. <br><br>
+:- a <scene name='86/868193/Beta-2-microglobulin_chain/6'>beta-2-microglobulin chain</scene> of 99 amino acids. <br>
-The first chain is made of two [https://en.wikipedia.org/wiki/Beta_sheet beta-sheets] and a set of 2 [[alpha helix]]. Each beta-sheet contains four antiparallel strands. The total molecular weight of the alpha chain is 33 kDa when not associated to any oligosaccharide and 55 kDa when the five oligosaccharides are associated to the chain.
+The first chain is made of two [https://en.wikipedia.org/wiki/Beta_sheet beta-sheets] and a set of 2 [[alpha helix]]. Each beta-sheet contains four antiparallel strands. The ligand binds between the two alpha-helices.
-The ligand binds between the two alpha-helices.
+Additionally, there are five <scene name='86/868193/Oligosaccharides/3'>oligosaccharides</scene><ref name="Structure"/> bound to the alpha chain via N-glycosylations, three of which have been clearly identified<ref name="oligo">Sriram, V., Willard, C.A., Liu, J., & Brutkiewicz, R.R.(2008). Importance of N-linked glycosylation in the functional expression of murine CD1d1. Immunology, 123:272–281.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2433293/</ref>. The total molecular weight of the alpha chain is 33 kDa when not associated to any oligosaccharide and 55 kDa when the five oligosaccharides are bound to the chain.<br>
-</p>
+CD1d molecules are structurally similar to [[Major Histocompatibility Complex Class I]], but present lipid antigens as opposed to peptides and the cleft where the ligand can bind its protein is different between MHC molecules and CD1d molecules. Indeed, the hydrophobic cleft of CD1d has a narrow opening.The recognition between the protein and its ligand occurs at a specific spot which creates an appropriate environment for the interaction to happen. This <scene name='86/868193/Site/2'>site</scene> is located at the A and F pockets in the region of the alpha helices<ref name="site">Schiefner, A.; Fujio, M.; Wu, D.; Wong, C.-H.; Wilson, I. A. Structural Evaluation of Potent NKT-Cell Agonists: Implications for Design of Novel Stimulatory Ligands. J Mol Biol 2009, 394 (1), 71–82. https://doi.org/10.1016/j.jmb.2009.08.061</ref>.
-<p align="justify">
-Additionally, there are two <scene name='86/868193/Oligosaccharides/3'>oligosaccharides</scene> bound to the alpha chain via [https://en.wikipedia.org/wiki/N-linked_glycosylation N-glycosylations] and three types of small molecules bound to that protein<ref name="Structure"/>. CD1d molecules are structurally similar to [[Major Histocompatibility Complex Class I]], but present lipid antigens as opposed to peptides and the cleft where the ligand can bind its protein is different between MHC molecules and CD1d molecules. Indeed, the hydrophobic cleft of CD1d has a narrow opening.The recognition between the protein and its ligand occurs at a specific spot which creates an appropriate environment for the interaction to happen. This <scene name='86/868193/Site/2'>site</scene> is located at the A and F pockets in the region of the alpha helices<ref name="site">Schiefner, A.; Fujio, M.; Wu, D.; Wong, C.-H.; Wilson, I. A. Structural Evaluation of Potent NKT-Cell Agonists: Implications for Design of Novel Stimulatory Ligands. J Mol Biol 2009, 394 (1), 71–82. https://doi.org/10.1016/j.jmb.2009.08.061</ref>.
 </p>

Sandbox Reserved 1660

From Proteopedia

Revision as of 19:57, 11 January 2022

Structure of mouse CD1d

Contents

Function

Role in the immune system

Ligands presented by CD1d

Structure

Impact of ligand-binding

Conformational variation

CD1d affinity

Applications

Immunotherapeutic tool

NKT cells marker

See Also

References

Views

Personal tools

Navigation

Search

Toolbox